Publications by authors named "C Mehats"

In Streptococcus pyogenes, the type II fatty acid (FA) synthesis pathway FASII is feedback-controlled by the FabT repressor bound to an acyl-Acyl carrier protein. Although FabT defects confer reduced virulence in animal models, spontaneous fabT mutants arise in vivo. We resolved this paradox by characterizing the conditions and mechanisms requiring FabT activity, and those promoting fabT mutant emergence.

View Article and Find Full Text PDF

Preeclampsia is a major hypertensive pregnancy disorder with a 50% heritability. The first identified gene involved in the disease is STOX1, a transcription factor, whose variant Y153H predisposes to the disease. Two rare mutations were also identified in Colombian women affected by the hemolysis, elevated liver enzyme, low platelet syndrome, a complication of preeclampsia (T188N and R364X).

View Article and Find Full Text PDF

Introduction: The global sequence of the pathogenesis of preterm labor remains unclear. This study aimed to compare amniotic fluid concentrations of extracellular matrix-related proteins (procollagen, osteopontin and IL-33), and of cytokines (IL-19, IL-6, IL-20, TNFα, TGFβ, and IL-1β) in asymptomatic women with and without subsequent spontaneous preterm delivery.

Material And Methods: We used amniotic fluid samples of singleton pregnancy, collected by amniocentesis between 16 and 20 weeks' gestation, without stigmata of infection (i.

View Article and Find Full Text PDF

In this study, we attempted to find genetic variants affecting gene expression (eQTL = expression Quantitative Trait Loci) in the human placenta in normal and pathological situations. The analysis of gene expression in placental diseases (Pre-eclampsia and Intra-Uterine Growth Restriction) is hindered by the fact that diseased placental tissue samples are generally taken at earlier gestations compared to control samples. The difference in gestational age is considered a major confounding factor in the transcriptome regulation of the placenta.

View Article and Find Full Text PDF
Article Synopsis
  • Preeclampsia (PE) is a pregnancy-related condition defined by issues like high blood pressure, protein in urine, and problems with the placenta, and is modeled in mice by the overexpression of the STOX1A transcription factor.
  • Research shows that STOX1A overexpression disrupts nitric oxide production and mitochondrial function in trophoblasts, which leads to a disturbance in the Krebs cycle and lower levels of a key metabolite, l-malate.
  • Administering tetrahydrobiopterin (BH4) restores these disrupted processes in vitro and in rodent models, suggesting BH4 could be a promising treatment for alleviating symptoms of preeclampsia, such as placental
View Article and Find Full Text PDF